BioCentury
ARTICLE | Company News

ImmuLogic deal

March 7, 1994 8:00 AM UTC

IMMU (Waltham, Mass.) received a $5 million payment from Marion Merrell Dow Inc. under the companies' 1992 agreement to develop IMUL's Allervax allergy therapeutics. IMUL has received $18 million of $...